133 related articles for article (PubMed ID: 38773777)
21. Factors influencing the parotid function in nasopharyngeal carcinoma treated with parotid-sparing radiotherapy.
Liu WS; Lee SP; Lee JK; Su MC; Chen GD; Lee HS; Lee H
Jpn J Clin Oncol; 2006 Oct; 36(10):626-31. PubMed ID: 17008345
[TBL] [Abstract][Full Text] [Related]
22. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.
Uzel EK; Karaçam S; Eliçin O; Uzel O
Strahlenther Onkol; 2013 Jul; 189(7):552-8. PubMed ID: 23748231
[TBL] [Abstract][Full Text] [Related]
24. Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
Trada Y; Lee MT; Jameson MG; Chlap P; Keall P; Moses D; Lin P; Fowler A
Radiother Oncol; 2023 Sep; 186():109745. PubMed ID: 37330056
[TBL] [Abstract][Full Text] [Related]
25. A longitudinal evaluation of early anatomical changes of parotid gland in intensity modulated radiotherapy of nasopharyngeal carcinoma patients with parapharyngeal space involvement.
Zhang Y; Lin C; Wu J; Jiang X; Lee SWY; Tam SY; Wu VWC
J Med Radiat Sci; 2017 Sep; 64(3):188-194. PubMed ID: 28258633
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
27. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
Tribius S; Sommer J; Prosch C; Bajrovic A; Muenscher A; Blessmann M; Kruell A; Petersen C; Todorovic M; Tennstedt P
Strahlenther Onkol; 2013 Mar; 189(3):216-22. PubMed ID: 23354440
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
30. Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.
van Dijk LV; Thor M; Steenbakkers RJHM; Apte A; Zhai TT; Borra R; Noordzij W; Estilo C; Lee N; Langendijk JA; Deasy JO; Sijtsema NM
Radiother Oncol; 2018 Sep; 128(3):459-466. PubMed ID: 29958772
[TBL] [Abstract][Full Text] [Related]
31. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.
Jen YM; Shih R; Lin YS; Su WF; Ku CH; Chang CS; Shueng PW; Hwang JM; Liu DW; Chao HL; Lin HY; Chang LP; Shum WY; Lin CS
Radiother Oncol; 2005 May; 75(2):204-9. PubMed ID: 15908027
[TBL] [Abstract][Full Text] [Related]
32. Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
Zhao DW; Fan WJ; Fang XM; Luo YR; Wei J; Chen NX; Zhang XX; Liu G; Li JF; Zang X; Li M; Meng L; Ma L
Radiother Oncol; 2022 Jul; 172():91-98. PubMed ID: 35584742
[TBL] [Abstract][Full Text] [Related]
33. [Clinical value of quantitative parameters by spectral CT in parotid gland tumor].
Su L; Xie CL; Sun Q; Gao JB
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Dec; 37(6):631-635. PubMed ID: 31875442
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.
Zhang Y; Ou D; Gu Y; He X; Peng W
Korean J Radiol; 2018; 19(4):758-766. PubMed ID: 29962882
[TBL] [Abstract][Full Text] [Related]
35. NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation.
Mavroidis P; Pearlstein KA; Moon DH; Xu V; Royce TJ; Weiner AA; Shen CJ; Marks LB; Chera BS; Das SK; Wang K
Radiat Oncol; 2021 Mar; 16(1):56. PubMed ID: 33743773
[TBL] [Abstract][Full Text] [Related]
36. Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
Pan XB; Liu Y; Huang ST; Chen KH; Jiang YM; Zhu XD
Medicine (Baltimore); 2019 Sep; 98(36):e17030. PubMed ID: 31490391
[TBL] [Abstract][Full Text] [Related]
37. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
Gai X; Wei Y; Tao H; Zhu J; Li B
Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
[TBL] [Abstract][Full Text] [Related]
38. Letter to the editor of radiotherapy and oncology regarding the paper titled "Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study." by Huang et al.
Sarode GS; Sarode SC; Anand R
Radiother Oncol; 2022 Dec; 177():252. PubMed ID: 36334695
[No Abstract] [Full Text] [Related]
39. Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients.
Berger T; Noble DJ; Yang Z; Shelley LE; McMullan T; Bates A; Thomas S; Carruthers LJ; Beckett G; Duffton A; Paterson C; Jena R; McLaren DB; Burnet NG; Nailon WH
Acta Oncol; 2023 Feb; 62(2):166-173. PubMed ID: 36802351
[TBL] [Abstract][Full Text] [Related]
40. A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy.
Li M; Zhang J; Zha Y; Li Y; Hu B; Zheng S; Zhou J
BMC Oral Health; 2022 Jun; 22(1):239. PubMed ID: 35715856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
